Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Adela has raised $5.0M in total funding. The most recent round was Convertible Note. The last funding was announced in April 2026.
Adela's investors include RA Capital Management, OrbiMed, Deerfield Management, Decheng Capital, Deerfield.
Adela is headquartered in Foster City, United States.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Adela is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adela — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/adela. Accessed July 19, 2026.
VCBacked. (2026). Adela — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/adela
{{cite web |title=Adela — Funding & Investors |url=https://www.vcbacked.co/company/adela |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated